Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma

Conditions:   Chordoma;   Locally Advanced Chordoma;   Metastatic Chordoma;   Unresectable Chordoma Interventions:   Biological: Nivolumab;   Biological: Relatlimab Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials